Evidence map›Paper›PMID 36031156›Full record

ArticleThe Journal of infection2023

The effect of tixagevimab-cilgavimab on clinical outcomes in patients with COVID-19: A systematic review with meta-analysis.

Yong Wang, Jun Zheng, Kongfu Zhu, Chengshi Xu, Daping Wang, Mengzhuo Hou

Open access · greenAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Yong WangDepartment of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Department of Anesthesiology, University Medical Center, Johannes Gutenberg-University Mainz, Langenbeckstr. 1, Mainz 55131, Germany.
Jun ZhengNeurorehabilitation Department, Zhongnan Hospital of Wuhan University, China.
Kongfu ZhuDepartment of Biomedical Engineering, Southern University of Science and Technology, China.
Chengshi XuDepartment of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Daping WangDepartment of Biomedical Engineering, Southern University of Science and Technology, China.
Mengzhuo HouDepartment of Biomedical Engineering, Southern University of Science and Technology, China. Electronic address: jackson0086@163.com.
Southern University of Science and Technology · CNWuhan University · CNJohannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Antibodies, MonoclonalClassificationHumansMeta-Analysis as TopicSystematic Reviews as TopicAntibodies, Monoclonalcilgavimabtixagevimab

Identifiers

PMID36031156
PMCPMC9420004
OpenAlexW4293511219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.